Search Cancer Clinical Trials
Home > Cancer (Oncology) > Research and Clinical Trials > Clinical Trials > Search Cancer Clinical Trials
Print

Research and Clinical Trials

Search Cancer Clinical Trials

Clinical Trials

New Search
Title   A Study of Pemetrexed & Carboplatin/Cisplatin or Gemcitabine & Carboplatin/Cisplatin With or Without IMC-1121B in Patients Previously Untreated With Recurrent or Advanced Non-small Cell Lung Cancer (NSCLC)
Description   The purpose of this study is to determine if patients with Stage 4 non-small cell lung cancer have a better outcome when treated with 1121B in combination with pemetrexed + carboplatin/cisplatin or gemcitabine + carboplatin/cisplatin than when treated with pemetrexed + carboplatin/cisplatin or gemcitabine + carboplatin/cisplatin alone.

Eligibility Criteria   To be eligible for this study, patients must meet several criteria, including but not limited to the following:

* Patient must be 18 Years and older

* Subject must have confirmed Non-small Cell Lung Cancer.

* Subject must have Stage IV disease at the time of study entry.
Principal Investigator   Missak Haigentz, MD
Contact Name   Yoko Eng, NP
Phone   (718) 920-2090
Contact Email   yeng@montefiore.org
Post Date   07/08/2010
Protocol Number   10-03-060/West
Status   Recruiting
Current Trial Type   Interventional
Montefiore Clinical Trial   No
CHAM Clinical Trial   No